Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA review
Biotech
FDA reconsidering Capricor’s snubbed DMD cell therapy
The agency has “lifted” the rejection letter for deramiocel, the company said, with a new decision expected by Aug. 22.
Darren Incorvaia
Mar 10, 2026 11:14am
HHS bans Anthropic's Claude AI tool
Mar 2, 2026 5:17pm
FDA adopts agentic artificial intelligence in latest AI push
Dec 1, 2025 5:33pm
FDA unveils hiring spree, new comms program to speed reviews
Nov 21, 2025 11:43am
FDA reveals 2nd round of 'national priority' voucher winners
Nov 6, 2025 3:12pm
FDA debuts priority review voucher with 2-month timeline goal
Jun 17, 2025 11:59am
